Los Angeles Capital Management LLC Raises Stock Position in Cabot Co. (NYSE:CBT)

Los Angeles Capital Management LLC raised its position in Cabot Co. (NYSE:CBT - Free Report) by 25.0% in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 23,794 shares of the specialty chemicals company's stock after buying an additional 4,756 shares during the period. Los Angeles Capital Management LLC's holdings in Cabot were worth $2,659,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Wolff Wiese Magana LLC purchased a new position in Cabot in the 3rd quarter valued at approximately $25,000. UMB Bank n.a. lifted its holdings in shares of Cabot by 53.9% during the 3rd quarter. UMB Bank n.a. now owns 371 shares of the specialty chemicals company's stock worth $41,000 after acquiring an additional 130 shares during the last quarter. CWM LLC lifted its holdings in shares of Cabot by 60.6% during the 2nd quarter. CWM LLC now owns 416 shares of the specialty chemicals company's stock worth $38,000 after acquiring an additional 157 shares during the last quarter. Farther Finance Advisors LLC lifted its holdings in shares of Cabot by 197.9% during the 3rd quarter. Farther Finance Advisors LLC now owns 417 shares of the specialty chemicals company's stock worth $47,000 after acquiring an additional 277 shares during the last quarter. Finally, EverSource Wealth Advisors LLC lifted its holdings in shares of Cabot by 33.4% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 475 shares of the specialty chemicals company's stock worth $48,000 after acquiring an additional 119 shares during the last quarter. Hedge funds and other institutional investors own 93.18% of the company's stock.

Insider Buying and Selling

In other Cabot news, EVP Hobart Kalkstein sold 34,759 shares of the firm's stock in a transaction that occurred on Monday, November 11th. The shares were sold at an average price of $115.23, for a total transaction of $4,005,279.57. Following the completion of the transaction, the executive vice president now owns 50,627 shares of the company's stock, valued at approximately $5,833,749.21. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. In other news, CEO Sean D. Keohane sold 25,617 shares of the stock in a transaction that occurred on Tuesday, September 3rd. The shares were sold at an average price of $101.55, for a total transaction of $2,601,406.35. Following the sale, the chief executive officer now owns 331,174 shares in the company, valued at $33,630,719.70. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, EVP Hobart Kalkstein sold 34,759 shares of the stock in a transaction that occurred on Monday, November 11th. The shares were sold at an average price of $115.23, for a total transaction of $4,005,279.57. Following the sale, the executive vice president now owns 50,627 shares in the company, valued at approximately $5,833,749.21. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 83,424 shares of company stock valued at $8,991,579 over the last three months. Corporate insiders own 3.07% of the company's stock.

Cabot Trading Down 1.4 %

Shares of NYSE CBT traded down $1.62 during midday trading on Wednesday, hitting $110.92. 515,461 shares of the company traded hands, compared to its average volume of 344,463. Cabot Co. has a 12-month low of $70.63 and a 12-month high of $117.46. The firm has a market cap of $6.08 billion, a P/E ratio of 16.46, a P/E/G ratio of 0.96 and a beta of 1.20. The stock has a 50-day moving average price of $109.78 and a 200 day moving average price of $101.98. The company has a debt-to-equity ratio of 0.68, a quick ratio of 1.36 and a current ratio of 2.08.

Cabot (NYSE:CBT - Get Free Report) last released its quarterly earnings results on Monday, November 4th. The specialty chemicals company reported $1.80 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $1.81 by ($0.01). Cabot had a return on equity of 26.60% and a net margin of 9.51%. The company had revenue of $1 billion during the quarter, compared to the consensus estimate of $1.01 billion. During the same period in the previous year, the company earned $1.65 earnings per share. Cabot's quarterly revenue was up 3.7% on a year-over-year basis. As a group, analysts expect that Cabot Co. will post 7.7 earnings per share for the current year.

Cabot Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, December 13th. Investors of record on Friday, November 29th will be paid a $0.43 dividend. This represents a $1.72 dividend on an annualized basis and a yield of 1.55%. The ex-dividend date of this dividend is Friday, November 29th. Cabot's payout ratio is currently 25.52%.

Analyst Upgrades and Downgrades

Several analysts have weighed in on the stock. Mizuho boosted their price target on shares of Cabot from $103.00 to $122.00 and gave the stock an "outperform" rating in a research note on Tuesday, November 5th. UBS Group lowered their price target on shares of Cabot from $103.00 to $98.00 and set a "neutral" rating for the company in a research note on Tuesday, August 6th. Finally, JPMorgan Chase & Co. downgraded shares of Cabot from a "neutral" rating to an "underweight" rating and set a $105.00 price target for the company. in a research note on Monday. One investment analyst has rated the stock with a sell rating, two have given a hold rating and two have issued a buy rating to the company's stock. Based on data from MarketBeat.com, the stock has a consensus rating of "Hold" and an average target price of $105.00.

Cabot Company Profile

Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.